New England Research & Management, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 360 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
New England Research & Management, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$1,114,000
+17.6%
18,890
-5.7%
0.80%
-1.5%
Q1 2020$947,000
+64.1%
20,040
+109.8%
0.81%
+109.0%
Q4 2019$577,0009,5500.39%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Bellevue Group AG 9,463,400$418,566,0006.01%
Tweedy, Browne Co LLC 2,722,988$120,438,0005.30%
BVF INC/IL 2,872,953$127,071,0005.25%
Sicart Associates LLC 253,976$11,233,0003.98%
Parkman Healthcare Partners LLC 241,945$10,701,0003.04%
Camber Capital Management LP 1,925,000$85,143,0002.61%
Privium Fund Management B.V. 148,807$6,589,0002.39%
SECTOR GAMMA AS 164,223$7,264,0001.87%
HANSEATIC MANAGEMENT SERVICES INC 10,993$486,0001.31%
BRANDYWINE MANAGERS, LLC 8,460$374,0001.23%
View complete list of IONIS PHARMACEUTICALS INC shareholders